Pharmacological Intervention with 4-Phenylbutyrate Ameliorates TiAl6V4 Nanoparticles-Induced Inflammatory Osteolysis by Promoting Macrophage Apoptosis

Macrophage apoptosis, along with inflammation in the interface membrane, has been demonstrated to be significant in the pathogenesis and development of particle-induced periprosthetic osteolysis and aseptic loosening. Additionally, the apoptosis of macrophages is considered an indicator of the resol...

Full description

Saved in:
Bibliographic Details
Main Authors: Guoyin Liu, Haiyang Gong, Tianting Bai, Yahui Fu, Xin Li, Junhao Lu, Jianning Zhao, Jianmin Chen
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Bioengineering
Subjects:
Online Access:https://www.mdpi.com/2306-5354/12/7/701
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849419151752298496
author Guoyin Liu
Haiyang Gong
Tianting Bai
Yahui Fu
Xin Li
Junhao Lu
Jianning Zhao
Jianmin Chen
author_facet Guoyin Liu
Haiyang Gong
Tianting Bai
Yahui Fu
Xin Li
Junhao Lu
Jianning Zhao
Jianmin Chen
author_sort Guoyin Liu
collection DOAJ
description Macrophage apoptosis, along with inflammation in the interface membrane, has been demonstrated to be significant in the pathogenesis and development of particle-induced periprosthetic osteolysis and aseptic loosening. Additionally, the apoptosis of macrophages is considered an indicator of the resolution phase of inflammation and the transition to normal tissue healing. Therefore, targeting macrophages presents a promising strategy for both the prevention and therapeutic management of periprosthetic osteolysis. In this study, we explored the therapeutic potential of chemical chaperone 4-phenylbutyrate (4-PBA) as a pharmacological intervention aimed at modulating macrophage behaviors, particularly focusing on the processes of apoptosis, inflammation, and osteoclastogenesis in a murine model of TiAl6V4 nanoparticle (TiNP)-induced osteolysis. The results derived from in vivo studies conducted on the murine model provide compelling evidence that TiNPs could trigger osteolysis, activate inflammatory cell infiltration, and promote the differentiation of osteoclasts, accompanied by a notable rise in apoptosis at the osteolytic interface periosteum. The severity of TiNP-induced osteolysis, chaotic bone morphology, extensive bone erosion and destruction, occurrence of infiltrating inflammatory cells, and quantity of osteoclasts were attenuated following co-intervention with 4-PBA. Furthermore, the levels of apoptosis, in conjunction with apoptosis-regulated proteins Bcl-2 and Bax, were accentuated following 4-PBA co-intervention, indicating that the TiNP-induced osteolytic interface periosteum environment exhibited a greater propensity for apoptosis due to the pharmacological intervention of 4-PBA. Notably, the use of 4-PBA as a standalone treatment demonstrated comparatively low levels of toxicity and was deemed to be experimentally safe in mice. These findings indicated that 4-PBA may ameliorate the severity of particle-induced osteolysis by inhibiting the inflammatory response and promoting macrophage apoptosis in a manner that may be beneficial for therapeutic strategies. Thus, pharmacological intervention with 4-PBA appears to be a viable option for addressing osteolysis and aseptic loosening resulting from exposure to wear particles, combining efficacy in promoting apoptosis with a favorable safety profile.
format Article
id doaj-art-fa0dfe5079014124884065c375c11ddb
institution Kabale University
issn 2306-5354
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
series Bioengineering
spelling doaj-art-fa0dfe5079014124884065c375c11ddb2025-08-20T03:32:12ZengMDPI AGBioengineering2306-53542025-06-0112770110.3390/bioengineering12070701Pharmacological Intervention with 4-Phenylbutyrate Ameliorates TiAl6V4 Nanoparticles-Induced Inflammatory Osteolysis by Promoting Macrophage ApoptosisGuoyin Liu0Haiyang Gong1Tianting Bai2Yahui Fu3Xin Li4Junhao Lu5Jianning Zhao6Jianmin Chen7Department of Orthopedics, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210093, ChinaDepartment of Rehabilitation, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210093, ChinaDepartment of Orthopedics, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210093, ChinaMedical School, Nanjing University, Nanjing 210001, ChinaDepartment of Orthopedics, Central Military Commission Joint Logistics Support Force 904th Hospital, Wuxi 214044, ChinaDepartment of Orthopedics, Nanjing Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210022, ChinaDepartment of Orthopedics, Nanjing Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210022, ChinaDepartment of Orthopedics, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210093, ChinaMacrophage apoptosis, along with inflammation in the interface membrane, has been demonstrated to be significant in the pathogenesis and development of particle-induced periprosthetic osteolysis and aseptic loosening. Additionally, the apoptosis of macrophages is considered an indicator of the resolution phase of inflammation and the transition to normal tissue healing. Therefore, targeting macrophages presents a promising strategy for both the prevention and therapeutic management of periprosthetic osteolysis. In this study, we explored the therapeutic potential of chemical chaperone 4-phenylbutyrate (4-PBA) as a pharmacological intervention aimed at modulating macrophage behaviors, particularly focusing on the processes of apoptosis, inflammation, and osteoclastogenesis in a murine model of TiAl6V4 nanoparticle (TiNP)-induced osteolysis. The results derived from in vivo studies conducted on the murine model provide compelling evidence that TiNPs could trigger osteolysis, activate inflammatory cell infiltration, and promote the differentiation of osteoclasts, accompanied by a notable rise in apoptosis at the osteolytic interface periosteum. The severity of TiNP-induced osteolysis, chaotic bone morphology, extensive bone erosion and destruction, occurrence of infiltrating inflammatory cells, and quantity of osteoclasts were attenuated following co-intervention with 4-PBA. Furthermore, the levels of apoptosis, in conjunction with apoptosis-regulated proteins Bcl-2 and Bax, were accentuated following 4-PBA co-intervention, indicating that the TiNP-induced osteolytic interface periosteum environment exhibited a greater propensity for apoptosis due to the pharmacological intervention of 4-PBA. Notably, the use of 4-PBA as a standalone treatment demonstrated comparatively low levels of toxicity and was deemed to be experimentally safe in mice. These findings indicated that 4-PBA may ameliorate the severity of particle-induced osteolysis by inhibiting the inflammatory response and promoting macrophage apoptosis in a manner that may be beneficial for therapeutic strategies. Thus, pharmacological intervention with 4-PBA appears to be a viable option for addressing osteolysis and aseptic loosening resulting from exposure to wear particles, combining efficacy in promoting apoptosis with a favorable safety profile.https://www.mdpi.com/2306-5354/12/7/701osteolysisaseptic looseningwear particles4-phenylbutyrateapoptosisinflammation
spellingShingle Guoyin Liu
Haiyang Gong
Tianting Bai
Yahui Fu
Xin Li
Junhao Lu
Jianning Zhao
Jianmin Chen
Pharmacological Intervention with 4-Phenylbutyrate Ameliorates TiAl6V4 Nanoparticles-Induced Inflammatory Osteolysis by Promoting Macrophage Apoptosis
Bioengineering
osteolysis
aseptic loosening
wear particles
4-phenylbutyrate
apoptosis
inflammation
title Pharmacological Intervention with 4-Phenylbutyrate Ameliorates TiAl6V4 Nanoparticles-Induced Inflammatory Osteolysis by Promoting Macrophage Apoptosis
title_full Pharmacological Intervention with 4-Phenylbutyrate Ameliorates TiAl6V4 Nanoparticles-Induced Inflammatory Osteolysis by Promoting Macrophage Apoptosis
title_fullStr Pharmacological Intervention with 4-Phenylbutyrate Ameliorates TiAl6V4 Nanoparticles-Induced Inflammatory Osteolysis by Promoting Macrophage Apoptosis
title_full_unstemmed Pharmacological Intervention with 4-Phenylbutyrate Ameliorates TiAl6V4 Nanoparticles-Induced Inflammatory Osteolysis by Promoting Macrophage Apoptosis
title_short Pharmacological Intervention with 4-Phenylbutyrate Ameliorates TiAl6V4 Nanoparticles-Induced Inflammatory Osteolysis by Promoting Macrophage Apoptosis
title_sort pharmacological intervention with 4 phenylbutyrate ameliorates tial6v4 nanoparticles induced inflammatory osteolysis by promoting macrophage apoptosis
topic osteolysis
aseptic loosening
wear particles
4-phenylbutyrate
apoptosis
inflammation
url https://www.mdpi.com/2306-5354/12/7/701
work_keys_str_mv AT guoyinliu pharmacologicalinterventionwith4phenylbutyrateamelioratestial6v4nanoparticlesinducedinflammatoryosteolysisbypromotingmacrophageapoptosis
AT haiyanggong pharmacologicalinterventionwith4phenylbutyrateamelioratestial6v4nanoparticlesinducedinflammatoryosteolysisbypromotingmacrophageapoptosis
AT tiantingbai pharmacologicalinterventionwith4phenylbutyrateamelioratestial6v4nanoparticlesinducedinflammatoryosteolysisbypromotingmacrophageapoptosis
AT yahuifu pharmacologicalinterventionwith4phenylbutyrateamelioratestial6v4nanoparticlesinducedinflammatoryosteolysisbypromotingmacrophageapoptosis
AT xinli pharmacologicalinterventionwith4phenylbutyrateamelioratestial6v4nanoparticlesinducedinflammatoryosteolysisbypromotingmacrophageapoptosis
AT junhaolu pharmacologicalinterventionwith4phenylbutyrateamelioratestial6v4nanoparticlesinducedinflammatoryosteolysisbypromotingmacrophageapoptosis
AT jianningzhao pharmacologicalinterventionwith4phenylbutyrateamelioratestial6v4nanoparticlesinducedinflammatoryosteolysisbypromotingmacrophageapoptosis
AT jianminchen pharmacologicalinterventionwith4phenylbutyrateamelioratestial6v4nanoparticlesinducedinflammatoryosteolysisbypromotingmacrophageapoptosis